matthew burke on chemotherapy-related aes versus immunotherapy-related aes
Published 10 years ago • 131 plays • Length 1:23Download video MP4
Download video MP3
Similar videos
-
1:31
matthew burke discusses chemotherapy-related adverse events and immunotherapy-related adverse events
-
1:14
matthew burke on the prevalence of immunotherapy-related adverse events
-
0:37
matthew burke on potential challenges facing nurses in the field of immunotherapy
-
3:32
multisystem immune-related aes with immunotherapy in nsclc
-
1:29
dr. brahmer on managing immune-related aes in lung cancer
-
0:45
it takes a team: treating adverse events
-
1:08
matthew burke on managing imaes
-
1:16
mitigating immune-related aes in patients with autoimmune conditions
-
1:25
immune-related adverse events: what to know
-
0:35
clinical requirements for managing immune-related adverse events
-
1:28
rajni kannan discusses immune related adverse events
-
1:27
dr. saba on immunotherapy/radiation combo in head and neck cancer
-
4:14
evaluation of costs associated with aes in urothelial cancer patients
-
5:21
pd-l1 immune-related adverse events
-
1:33
sitc clinical practice guidelines on immune checkpoint inhibitor-related adverse events
-
3:39
tumor-related immune checkpoints and the development of targeted cancer immunotherapies
-
56:25
dissecting toxicities of immune checkpoint inhibitors with dr. douglas johnson, m.d., msci
-
1:34
dr. naidoo on the mechanisms behind immune-related adverse events in lung cancer
-
14:42
managing toxicities associated with immune-checkpoint inhibitors